Prolotherapy - Minimally Invasive Treatment for Chronic Injury

Palm Beach Spine & Diagnostic Institute offers Prolotherapy as an effective, Minimally Invasive Treatment for Chronic Injury

LAKE WORTH, FL - Palm Beach Spine & Diagnostic Institute announces the offering of a newly emerging technique, Prolotherapy, as a minimally invasive treatment option for those living with chronic pain and repetitive re-injury. The treatment is performed at Palm Beach Spine & Diagnostic Institute pain management and treatment center, 2290 10th Avenue North, Suite 600, Lake Worth, Florida.

Recently endorsed by the Florida Academy of Pain Medicine and reported in The New York Times, Prolotherapy is also known as Proliferative Injection Therapy or Regenerative Injection Therapy (RIT). Prolotherapy is sparking renewed interest, particularly with regard to treating repetitive stress injuries in professional athletes. In 2005, the Mayo Clinic endorsed prolotherapy, saying it may be helpful when ligament or tendon pain fails to respond to prescribed physical therapy. The procedure is endorsed by former Surgeon General C. Everett Koop, and is part of clinical trial being conducted by National Center for Complementary and Alternative Medicine (National Institute of Health.)

Prolotherapy uses injections of a dextrose (sugar water) solution mediated by multiple growth factors into the injured ligaments or tendons to produce a natural healing effect. Prolotherapy mimics the body's natural response to an injury - producing a desired inflammation in the injured tissue, increasing blood supply and nutrients to the area, and stimulating tissue repair.

"We are seeing great success with this technique with an increase in effective movement and stability of the joint," says Lawrence Gorfine, MD, co-founder of Palm Beach Spine & Diagnostic Institute. In a recent Florida Academy of Pain Medicine position paper, Dr. Gorfine and 12 medical colleagues conducted a review of 40 case studies with 530,00 participants, and noted an improvement of 45% to 82% in terms of return to work and previous functional activities.